You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EML4-RET

Showing 1 - 25 of 382
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Either EML4-ALK Gene Rearrangements or T790M EGFR Mutation in

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Hollywood, Florida
    • +1 more
    Sep 29, 2021

    NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Scottsdale, Arizona
    • +84 more
    Oct 10, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Urinary Retention, Inguinal Hernia Trial in Baden (TAMSULOSIN Mepha Ret Depocaps 0.4 mg, Control Intervention)

    Recruiting
    • Urinary Retention
    • Inguinal Hernia
    • TAMSULOSIN Mepha Ret Depocaps 0.4 mg
    • Control Intervention
    • Baden, Aargau, Switzerland
      Kantonsspital Baden
    Dec 1, 2021

    Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic

    Recruiting
    • Untreated Advanced NSCLC Patients
    • FISH Identified ALK Fusion Positive or Negative
    • ALK inhibitor
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Jul 31, 2020

    Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • HS-10365 capsules
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Nov 22, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +37 more
    • Birmingham, Alabama
    • +171 more
    Aug 24, 2022

    MDD Trial in Ames (Resistance Exercise Training)

    Active, not recruiting
    • Major Depressive Disorder
    • Resistance Exercise Training
    • Ames, Iowa
      Iowa State University
    Jan 12, 2023

    RET-altered Solid Tumors Trial in Shanghai (APS03118)

    Recruiting
    • RET-altered Solid Tumors
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Dec 8, 2022

    Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

    Active, not recruiting
    Has Results
    • Solid Tumor
    • Medullary Thyroid Cancer
    • Guangzhou, Guangdong, China
    • +12 more
    May 9, 2022

    Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

    Active, not recruiting
    • Advanced Nonhaematologic Malignancies
    • Philadelphia, Pennsylvania
    • +20 more
    Sep 23, 2022

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

    Recruiting
    • Malignant Thyroid Gland Neoplasm
    • +6 more
    • Quality-of-Life Assessment
    • +3 more
    • Ann Arbor, Michigan
    • +1 more
    Jan 24, 2023

    Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Aug 16, 2022

    NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Berazategui, Buenos Aires, Argentina
    • +195 more
    Jan 30, 2023

    Eyelid Dermatochalasis, Dermatochalasis Trial in Miami (Restorative Eye Treatment (RET) cream, INhance with Trihex Technology)

    Active, not recruiting
    • Eyelid Dermatochalasis
    • Dermatochalasis
    • Restorative Eye Treatment (RET) cream
    • INhance with Trihex Technology
    • Miami, Florida
      Bascom Palmer Eye Institute, University of Miami
    May 16, 2022

    Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

    Recruiting
    • Medullary Thyroid Cancer
    • Birmingham, Alabama
    • +148 more
    Jan 18, 2023

    Ventilator-associated Pneumonia (VAP) Trial in Mugla (reticulocyte/hemoglobin (Ret-He) ratio)

    Suspended
    • Ventilator-associated Pneumonia (VAP)
    • reticulocyte/hemoglobin (Ret-He) ratio
    • Muğla, Kötekli, Turkey
      Mugla Sitki Kocman Universty
    Jan 24, 2022

    NSCLC Trial in Guangzhou (HA121-28 tablet)

    Recruiting
    • NSCLC
    • HA121-28 tablet
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Centre
    Aug 2, 2022

    ALK-positive NSCLC (NSCLC), RET-positive NSCLC (NSCLC), RET-positive Thyroid Cancer Trial in Irvine, Boston (Alectinib)

    Terminated
    Has Results
    • ALK-positive Non-small Cell Lung Cancer (NSCLC)
    • +2 more
    • Irvine, California
    • +3 more
    Aug 30, 2021

    Cesarean Section, Postpartum, Abdominal Pain Trial in Clermont-Ferrand, Vichy (Winback® on, Winback® off, self-massage of the

    Not yet recruiting
    • Cesarean Section
    • +3 more
    • Winback® on
    • +2 more
    • Clermont-Ferrand, France
    • +1 more
    Jan 20, 2023

    Infected Immature Permanent Teeth Trial in Singapore (RET using antibiotics (Ciprofloxacin and Metronidazole), RET using

    Completed
    • Infected Immature Permanent Teeth
    • RET using antibiotics (Ciprofloxacin and Metronidazole)
    • RET using non-setting Calcium Hydroxide
    • Singapore, Singapore
    • +1 more
    Oct 13, 2021

    NSCLC, NSCLC Metastatic, NSCLC Recurrent Trial in Worldwide (Alectinib)

    Terminated
    • Non-small Cell Lung Cancer
    • +2 more
    • Brussels, Belgium
    • +18 more
    Aug 23, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

    Not yet recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +3 more
    • Chang chun, Jilin, China
      Jinlin Province Cancer Hosipital
    Dec 21, 2022

    Solid Tumor Trial in Shanghai (HS-10365)

    Recruiting
    • Solid Tumor
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Jan 24, 2022